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In contrast to infection of superficial tissues, Streptococcus pyogenes infection of deeper tissue can be
associated with a significantly diminished inflammatory response, suggesting that this bacterium has the
ability to both promote and suppress inflammation. To examine this, we analyzed the behavior of an S. pyogenes
mutant deficient in expression of the cytolytic toxin streptolysin S (SLS) and evaluated events that occur
during the first few hours of infection by using several models including injection of zebrafish (adults, larvae,
and embryos), a transepithelial polymorphonuclear leukocyte (PMN) migration assay, and two-photon mi-
croscopy of mice in vivo. In contrast to wild-type S. pyogenes, the SLS mutant was associated with the robust
recruitment of neutrophils and significantly reduced lethal myositis in adult zebrafish. Similarly, the mutant
was attenuated in embryos in its ability to cause lethality. Infection of larva muscle allowed an analysis of
inflammation in real time, which revealed that the mutant had recruited PMNs to the infection site. Analysis
of transepithelial migration in vitro suggested that SLS inhibited the host cells’ production of signals chemo-
tactic for neutrophils, which contrasted with the proinflammatory effect of an unrelated cytolytic toxin,
streptolysin O. Using two-photon microscopy of mice in vivo, we showed that the extravasation of neutrophils
during infection with SLS mutant bacteria was significantly accelerated compared to infection with wild-type
S. pyogenes. Taken together, these data support a role for SLS in the inhibition of neutrophil recruitment
during the early stages of S. pyogenes infection.
The initial encounter with the host poses several challenges
for extracellular bacterial pathogens that cause acute self-lim-
iting diseases. For example, the bacterium must first establish
a niche on the mucosal epithelium, which will likely require it
to out-compete the resident flora. Once established, the bac-
terium must multiply, often to high numbers, while at the same
time avoiding the host’s attempt at immune clearance. The
ultimate goal of the pathogen is to maximize its potential for
transmission to a new host or to enter into a quiescent state to
persist indefinitely in the host. The ability to balance between
these tasks implies that these bacteria have the ability to both
promote and suppress host responses at various stages of the
infection.
Insight into the stage-specific contributions of pro- versus
anti-inflammatory virulence factors will be important for un-
derstanding the pathogenesis of the myriad diseases caused by
Streptococcus pyogenes (group A streptococcus). This gram-
positive bacterium causes diseases of soft tissue that most
frequently involve the more superficial layers of tissue (impe-
tigo, pharyngitis, erysipelas, and cellulitis), but it can also
sometimes be highly destructive of fascia, adipose tissue, and
muscle and be associated with high rates of morbidity and
mortality (necrotizing fasciitis and myositis). As a general rule,
the late stages of all these diseases are characterized by robust
inflammation (6, 14). However, a distinct absence of inflam-
mation is not an uncommon presentation for advanced necro-
tizing fasciitis (32), and a deficiency of polymorphonuclear
leukocytes (PMNs) upon histopathological examination of in-
fected tissues is associated with a significantly increased risk of
mortality from this disease (1). Thus, S. pyogenes appears to
have the capacity to both suppress and stimulate inflammation,
and the balance between these activities may be influenced by
strain differences and/or stage- and tissue-specific cues in a
manner that can affect the outcome of infection.
Unfortunately, understanding the contribution of many pro-
or anti-inflammatory factors to a specific stage of any S. pyo-
genes disease has typically been problematic. A prominent ex-
ample is streptolysin S (SLS), a potent cytolysin that has been
reported to possess both proinflammatory (26) and anti-in-
flammatory activities (35, 53, 57) and whose contribution to
virulence in a number of animal models of S. pyogenes disease
has been the subject of several conflicting reports (for a review,
see references 25 and 75). A difficulty in studying SLS has been
its intrinsic instability, which has made its biochemical charac-
terization difficult. However, analysis of SLS stabilized in com-
plex with various carrier molecules has suggested that it is
composed of a peptide with a molecular mass of approximately
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2.8 kDa (2). Consistent with this, a nine-gene operon resem-
bling the gene clusters that encode bacteriocin-like antimicro-
bial peptides has been shown to be both necessary and suffi-
cient for production of SLS (reviewed in reference 55). Similar
to several other bacteriocin operons, the first gene in the SLS
operon (sagA) encodes a protein with a predicted double-
glycine signal sequence followed by a 30-amino-acid mature
region that is likely secreted while the remaining genes (sagB
to sagI) encode proteins for posttranslational modification,
membrane transport, and an immunity factor (55). Modifica-
tion likely involves heterocycle formation catalyzed by Sag-
BCD (44). While SLS is normally nonantigenic, the observa-
tion that antibodies raised against a synthetic peptide that
corresponds to the predicted SagA mature region can neutral-
ize the cytolytic activity of SLS has provided additional evi-
dence to support a bacterocin peptide-like nature for SLS (15).
Membrane damage associated with SLS cytotoxicity occurs
via the introduction of small pores (7, 28), and almost any
eukaryotic cell type is susceptible (29). The cytotoxin is rapidly
lethal when injected into rabbits, causing intravascular hemo-
lysis and cardiac abnormalities (29). However, despite this
impressive toxicity, analyses of mutants engineered to be phe-
notypically SLS-deficient (SLS) have not yielded a definitive
answer on the role of SLS in pathogenesis or its importance to
the disease process. For example, several studies in murine
models of lethal infection have found that SLS mutants are
only modestly attenuated under conditions where death is a
consequence of systemic dissemination (24, 67). In contrast,
other studies that have analyzed the ability of SLS mutants to
form local ulcerative lesions in murine subcutaneous tissue
have generally observed a higher degree of attenuation (3,
17, 24), suggesting that SLS may act to promote local growth
of S. pyogenes in tissue. In these latter studies, attenuation
was associated with markedly less inflammatory tissue dam-
age than wild-type infection, suggesting that SLS is proin-
flammatory. However, an anti-inflammatory effect early in
infection could also lead to a subsequent reduction in tissue
damage at latter time points since the mutant would be
more rapidly cleared in the absence of the ability to block
inflammatory cell recruitment. Thus, whether attenuation
results from the loss of pro- or anti-inflammatory activities
contributed by SLS is not clear.
Greater insight into the contribution of SLS to pathogenesis
will require a more detailed characterization of its influence on
the inflammatory response during the first few hours of infec-
tion. In the present study, we analyzed the behavior of an SLS
mutant in several models that are well suited for the examina-
tion of the first few hours of infection, including infection of
adult, embryo, and larval zebrafish; in vitro transepithelial
PMN migration; and two-photon intravital microscopy of in-
fected murine soft tissue. Taken together, these studies sup-
port a role for SLS in suppressing PMN migration to the sites
of streptococcal infection during the early period of infection,
and this function is independent of the lytic activity of SLS but
likely dependent on an ability to inhibit the production of
chemotactic signals by local host cells. The inhibition of PMN
recruitment soon after infection might serve as an important
immune escape mechanism in streptococcal pathogenesis.
MATERIALS AND METHODS
Strains, media, and culture conditions. Molecular cloning experiments used
Escherichia coli Top Ten (Invitrogen), and experiments with S. pyogenes used
wild-type strains HSC5 (30) and JRS4 (66). Strain Emm is an M protein-
deficient mutant derived from HSC5 (10), and SLO1 is a streptolysin O (SLO)-
deficient mutant derived from JRS4 (65). Routine culture of S. pyogenes em-
ployed Bacto Todd-Hewitt medium (Becton-Dickinson) supplemented with
0.2% BBL yeast extract (Becton-Dickinson) (THY medium) in sealed tubes
without agitation. For infection of animals, THY medium was supplemented
with 2% (wt/vol) Bacto Proteose Peptone 3 (Becton-Dickinson) (TP medium).
To produce solid medium, Bacto agar (Becton-Dickinson) was added to THY
medium to a final concentration of 1.4%, and unless otherwise indicated, all solid
cultures were incubated under anaerobic conditions produced using a commer-
cial gas generator (BBL GasPak; catalog no. 70304; Becton-Dickinson). When
appropriate, spectinomycin was added to the medium at 100 mg/ml for both E.
coli and S. pyogenes. (See strain table in supplementary material.)
DNA techniques. Plasmid DNA was isolated by standard techniques and was
used to transform E. coli by the method of Kushner (41) and to transform S.
pyogenes by electroporation as previously described (5). Restriction endonucle-
ases, ligases, kinases, and polymerases were used according to the manufacturers’
recommendations. Chromosomal DNA was purified from S. pyogenes as previ-
ously described (5). The fidelity of all DNA molecules generated by PCR was
confirmed by DNA sequence analyses performed by an outside vendor
(SeqWright, Houston, TX).
Insertional inactivation of sagH. Based on prior reports (17, 56), an SLS
mutant was constructed by insertional disruption of sagH (Spy0745) (23) by
methods described elsewhere (48). Briefly, primers sagHdisruption up (AAA
CGC GGA TCC GAT GAT CGT TAT TTT AAG TTT TGC C) and sagHdi-
sruption down (AAA CGC GAG CTC CCC ATT TAA TAG GAG ATA TAT
TCG AC) were used to amplify a 928-bp fragment within sagH from HSC5
chromosomal DNA. Subsequent insertion of the fragment between the BamHI
and SstI of the integrational plasmid pSPC18 (49) using the sites embedded in
the primers (underlined) generated the plasmid pATL28. Integration of pATL28
into the HSC5 chromosome via homologous recombination produced strain
SagH (SLS). The chromosomal structure of this mutant was verified by PCR
using the appropriate primers: sagH check up (GC CAG ATT TAA TAG GAG
ATA TAT TCG AC) and sagH check down (GCG CTT TAT CTT AAC AAA
TAG AG). (See primer table in supplementary material.)
Phenotypic characterization of SagH (SLS). The SLS-dependent hemoly-
sis of the wild-type strain andSagH was confirmed as described previously (58).
As expected, SagH did not produce detectable levels of SLS-dependent hemo-
lysis of erythrocytes (data not shown). The growth rates of wild-type and SagH
were compared at both 37°C and 30°C as follows. Cultures were initiated from
overnight growth in THY medium of cells that had been washed once with an
equal volume of phosphate-buffered saline (PBS) (pH 7.4) to obtain an initial
optical density at 600 nm (OD600) of 0.01. Growth was monitored as the change
in OD600 over time. The ability of all streptococcal strains to adhere to kerati-
noctyes was routinely monitored as described previously (73). A hemolysis assay
for detection of SLO activity was performed as described previously (65). The
presence of M protein was analyzed by Western blotting. Compared to its
wild-type parent strain, SagH demonstrated no growth or adherence defects or
deficiency in the expression of M protein or in SLO activity (data not shown).
All animals were maintained and all animal studies were performed at the
Washington University School of Medicine using protocols approved by the
Animal Studies Committee in accordance with federal regulations.
Infection of zebrafish. Outbred 6-month-old adult male zebrafish (Danio rerio)
of the ZDR wild-type strain were obtained from a commercial breeder (Aquatica
Tropicals, Plant City, FL) and used to compare the ability of wild-type and
mutant streptococci to cause a fatal myositis, as described previously (54). Strep-
tococci were cultured overnight in TP medium, diluted 1:100 in fresh medium,
cultured to an OD600 of 0.300 at 37°C, and briefly sonicated to disrupt the
streptococcal chains. Groups of 10 zebrafish each were then injected with 105
CFU in a volume of 10 l or with an equivalent volume of sterile TP medium in
the case of mock infection. Survival was monitored for 5 days, and any differences
in survival between groups infected with wild-type or mutant strains were tested
for significance as described previously (54). Data presented are from a repre-
sentative of three independent experiments.
Embryos were derived from wild-type ZDR zebrafish by natural mating and
were maintained in embryo medium (76) for 18 h postfertilization and then
moved to 0.003% phenyl-thiourea in embryo medium to prevent melanization
(76). At 32 h postfertilization, embryos were dechorionated, as described previ-
ously (76), immediately prior to infection. Groups of 15 embryos each were then
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injected (FemtoJet; Eppendorf) in the yolk sac essentially as described previ-
ously (18, 76) with approximately 103 CFU of streptococci (in 1.0 l) that were
prepared as described above, with the exception that bacteria were resuspended
in PBS. Injection doses were quantitated by serial dilution of the suspension used
for inoculation and plating on THY plates. Mock injection was with an equiva-
lent volume of sterile PBS. Embryos were examined by microscopy every 2 h for
the loss of viability and were considered deceased on the basis of these criteria:
(i) an absence of any visible ventricular contraction upon examination of the
heart and (ii) conversion from a transparent to an opaque appearance. Any
deaths that occurred within 2 h postinjection were attributed to injection trauma
and were excluded from the study. Any differences in survival between the wild
type and mutant were analyzed for significance as described for infection of adult
fish.
Larvae derived from the pu.1 transgenic line (36) by natural mating were
raised by standard methods (76) and were maintained in embryo medium for up
to 7 days postfertilization. Streptococci were intrinsically labeled with Cell-
Tracker Orange ([CTO] catalog number C-2927; Molecular Probes) as follows.
Bacterial strains were cultured as described earlier, harvested by centrifugation,
and then resuspended in prewarmed PBS containing 0.015 mM CTO. Following
a 30-min incubation at 37°C, the labeled streptococci were harvested by centrif-
ugation and resuspended in prewarmed TB medium. After an additional 30-min
incubation at 37°C, streptococci were washed twice in PBS and then resuspended
in PBS. This treatment had no effect on streptococcal viability as assessed on the
basis of growth rates (data not shown). Larvae were then injected under tricaine
anesthesia (0.25 mg/ml) at the midline of the dorsal muscle immediately anterior
to the dorsal fin with approximately 103 CFU of streptococci.
Quantification of PMNs. Infected adult zebrafish (three per group) were
euthanized with tricaine (0.5 mg/ml) at 3-h intervals up to 48 h postinfection and
immersed in fixative (Histochoice; Sigma). Tissues were then paraffin embedded
and stained with hematoxylin-eosin by standard methods. PMNs were identified
based on their characteristic multilobed nuclei. Infected larvae were examined
every 2 h by fluorescence microscopy (Leica model DMIRE2) and observed for
fluorescence using both the green fluorescent protein ([GFP] PMNs) and rho-
damine filters (bacteria). PMNs were identified by their green fluorescence. The
number of PMNs in tissue was then assessed as described by Klein et al. (40).
Images were captured using a QImaging Retiga 1350 EX charged-coupled-
device camera and OpenLab software (Improvision) and processed for publica-
tion using Canvas X (ACD Systems).
Bacterial quantification. In selected experiments, groups of three adults or five
embryos each were euthanized with tricaine every 6 h up to 24 h postinfection.
The numbers of bacterial CFU for adults were determined as previously de-
scribed (69). Bacterial load in embryos was determined as previously described
(71).
Injection and imaging of mice. Female adult LysM-eGFP mice, were obtained
from Klaus Ley (Robert M. Berne Cardiovascular Research Center, University
of Virginia) who backcrossed the originally generated mice from T. Graf (Albert
Einstein College of Medicine, Bronx, NY) to the B6 background (22). C57BL6
LysM-eGFP mice in which neutrophils and macrophages express the enhanced
GFP (eGFP) were injected in the footpad with 1  108 CFU of S. pyogenes,
either the wild-type or SLS strain, in5 l of PBS. During the imaging process,
mice were anesthetized with isofluorane for restraint and to avoid psychological
stress on the animal. VetBond (3 M) was used to secure the paw to the glass
coverslip at the bottom of the imaging chamber, and PBS was added to cover the
tissue. The mouse’s core body temperature was maintained with a warming pad
(Braintree Scientific) set to 37°C. To label blood vessels during imaging, 1 mg of
dextran tetramethylrhodamine (molecular weight of 2,000,000; Invitrogen), was
injected by intravenous or retro-orbital route. The rear footpad and toes were
imaged for a period of 1 h before the mouse was euthanized while deeply
anesthetized. Time-lapse imaging was performed using a custom-built dual laser
video-rate 2P microscope. GFP-labeled neutrophils and rhodamine dextran-
labeled blood vessels were excited by a Chameleion XR Ti:sapphire laser (Co-
herent) tuned to 820 nm. Fluorescence emission was passed through 490-nm and
560-nm dichroic mirrors placed in series and detected as red (560 to 650 nm),
green (490 to 560 nm), and blue (490 nm) channels by three head-on bialkali
photomultiplier tubes. A customized version of ImageWarp (A&B Software) was
used to control the various hardware devices during real-time acquisition and to
process and archive the image data. Each plane consists of an image of 200 mm
by 225 mm (x and y, 2 pixel/mm). Z-stacks were acquired by taking 31 sequential
steps at 2.5-mm spacing. To increase signal contrast, we averaged 15 video
frames for each slice with a 5-s delay between steps. Multidimensional rendering
was performed with Imaris (Bitplane), and cell tracking was performed with
PicViewer software (John Dempster, University of Strathclyde) (77).
Neutrophil tracking. Neutrophils were identified by their characteristic shape
and movements and their fluorescence, which is brighter than that of macro-
phages/monocytes, as previously described (22, 78). Neutrophils were classified
as either inside or outside of vessels based on their colocalization with intrave-
nously injected rhodamine dextran and on their characteristic flow and rolling
behavior. Neutrophil migration in the connective tissue was tracked by measur-
ing the cell’s center of mass. Cell velocity was calculated on a cell track basis and
reported as median velocity standard error of the mean. The cell’s meandering
index was obtained by dividing the cell’s displacement from the origin (after 5
min) by the track length. Values above 0.75 indicate highly directional migration,
consistent with chemotactic behavior.
Human PMN isolation. Neutrophils were isolated from the venous blood of
healthy volunteers using dextran sedimentation, followed by Ficoll density gra-
dient centrifugation and hypotonic lysis of contaminating red blood cells as
described previously (61). PMN viability was greater than 95% as assessed by
trypan blue exclusion and greater than 95% pure as determined by visualization
of nuclear morphology after staining (Hema 3; Fischer Scientific). For migration
assays, cells were resuspended in prewarmed chemotaxis medium (see below) at
a concentration of 107 cells/ml and used immediately.
Preparation of inverted epithelial layers. The HaCaT human keratinocyte cell
line (4) was cultured as described previously (73) in Dulbecco’s modified Eagle’s
medium with 8 mM L-glutamine, 25 mM HEPES, and 5% (vol/vol) fetal calf
serum (all final concentrations). Trypsinized cells were resuspended to a con-
centration of 3 106 cells/ml, and 50 l of the suspension was seeded on inverted
Transwell inserts (0.33-cm2 polycarbonate membranes with 3-m diameter
pores; catalog number 3472; Corning). The cells were allowed to attach to the
membranes in a humidified 5% CO2 atmosphere at 37°C for 16 h and were then
transferred to 24-well plates with 0.6 ml of fresh medium in each well, and 0.2 ml
of medium was added to the basolateral chamber. After 10 to 11 days of incu-
bation with medium refreshed every 2 days, confluent cell layers were obtained.
The electrical resistance of confluent monolayers was not detectable by tradi-
tional methods; therefore, monolayer integrity was determined by assessing the
permeability to fluid as described previously (47). A monolayer was accepted as
polarized if the basolateral chamber remained completely full of medium and did
not equilibrate with the apical chamber after an overnight incubation.
PMN transepithelial migration assay. At the beginning of each experiment,
inverted HaCaT monolayers were washed three times with chemotaxis medium,
which consists of the HaCaT medium described above prepared without serum
and phenol red. Overnight cultures of bacteria grown in THY broth were washed
once in PBS and suspended in chemotaxis medium at a concentration of 108
CFU/ml. Transwell inserts were lifted from each well and placed in a moist
chamber with the cell layer facing up. An aliquot of the bacterial suspension (25
l) or an equivalent volume of sterile medium was placed on top of the epithelial
layers (a multiplicity of approximately 10 CFU/cell) and incubated for 60 min at
37°C. Nonadherent bacteria were removed by immersing the inserts three times
in culture trays containing chemotaxis medium. The cell layers were inverted and
transferred into new 24-well culture plates (Ultra Low attachment plates; Corn-
ing catalog number 3473) containing 0.6 ml of chemotaxis medium. An aliquot of
the PMN suspension (106 cells) was then added to the basolateral chamber, and
following a 60-min incubation at 37°C, the contents of the apical chamber were
mixed by gentle pipetting and then transferred to a centrifuge tube. To quantify
transepithelial migration of PMNs, an aliquot of this suspension was examined by
microscopy, and the number of PMNs was enumerated using a hemocytometer.
The number of PMNs recruited by each mutant is shown as a percentage of the
number recruited by the wild-type strain, and the data presented represent the
mean and standard deviation of the mean derived from at least three indepen-
dent experiments, with samples analyzed in triplicate. For the interleukin-8
(IL-8) assay, 100 l of chemotaxis medium was added to the basolateral cham-
ber, and 600 l of chemotaxis medium was present in the apical chamber. After
a 1-h incubation at 37°C, tissue culture supernatants from both chambers were
collected and evaluated for IL-8 using an IL-8 Singleplex assay according to the
manufacturer’s instructions (Bio-Rad Laboratories, Hercules, CA). The results
represent the mean and standard deviation of the mean from three independent
experiments with 10 replicates for each sample.
Production of ROS. The production of reactive oxygen species (ROS) by
human PMNs was measured using a kinetic assay for fluorescence of an indicator
compound, 2,7-dihydrodichlorofluorescein diacetate (catalog number C2938;
Molecular Probes). Purified human PMNs were incubated with a 10 M con-
centration of the reagent for 30 min at room temperature in PBS. The treated
PMNs (106 cells) were used in a transepithelial migration assay performed as
described earlier with the following modifications. The HaCaT cells were grown
on permeable cell culture inserts that block transmission of light such that
independent fluorescence signal measurements can be taken from the top and
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bottom compartment in the appropriate companion plate (BD Falcon Fluoro-
Blok; catalog numbers 351151 and 353504, respectively) and transferred to a
heated microplate fluorometer (Synergy 2; BioTek) at the onset of the migration
experiment. It was determined that HaCaT cell growth and PMN transepithelial
migration under these conditions were similar to results with the standard assay.
The amount of ROS generated in the bottom compartment was measured for
120 min at 37°C using excitation and emission wavelengths of 485 and 528 nm,
respectively, and normalized to the number of PMNs migrated. Data are relative
fluorescent units per 104 PMNs and represent the mean and standard deviation
of five samples.
PMN apoptosis. The ability of S. pyogenes to induce PMNs to undergo apop-
tosis was measured as follows. Bacterial and PMN suspensions were prepared in
chemotaxis medium as described for the transepithelial migration assay above
and combined at a ratio of approximately 10 CFU/cell. Samples were transferred
to a 37°C incubator with 5% CO2 for 60 or 120 min prior to analysis. Control
PMNs were incubated with medium in the absence of bacteria. Apoptosis was
evaluated by determination of the number of PMNs that demonstrated surface
localization of phosphatidylserine as revealed by staining with annexin V conju-
gated to the fluorochrome phycoerythrin (PE). Staining used a commercial kit
(catalog number 559763; BD Biosciences) and was conducted according to the
protocol provided by the manufacturer. Fluorescence of individual cells was
measured using a flow cytometer (FACSCalibur; Beckman-Coulter), and mean
fluorescence values were determined from a minimum of 5  104 cells within an
analysis region corresponding to the nonfragmented neutrophils identified using
Cell Quest software (BD Biosciences). The number of apoptotic cells in samples
incubated with bacteria is shown as a ratio relative to the number of annexin
V-PE-positive cells in uninfected control samples and reflects the mean and
standard deviation of two independent experiments, each of which was analyzed
in duplicate.
Statistical analyses. Data were analyzed as means 1 standard deviation from
the mean. Kaplan-Meier product limit estimates of survival curves were used to
compare infection by wild-type and mutant streptococci, and any differences in
survival were tested for significance as described previously (54). Where noted,
the significance of differences observed between experimental groups in other
assays was evaluated using a Student’s t test. Extravasation kinetics were com-
pared using both Pearson (parametric) and Spearman (nonparametric) correla-
tions. Median track velocities and the meandering index were compared by a
Mann-Whitney test. P values of less than 0.05 were considered statistically
significant.
RESULTS
SLS mutants are attenuated in the zebrafish model of
necrotic myositis. Inactivation of any gene in the SLS operon
produces a mutant that is phenotypically defective in produc-
tion of detectable SLS (56). Based on this, we generated an
insertion mutation in sagH in wild-type strain HSC5, whose
virulence has been extensively characterized in the zebrafish
model of necrotic myositis that reproduces several features
commonly observed in S. pyogenes infection of human muscle
(54). The virulence of this mutant was then compared to its
wild-type parent for its ability to cause disease in zebrafish.
Both streptococcal strains were inoculated into the dorsal mus-
cle of zebrafish at a dose approximately 10-fold the 50% lethal
dose for the wild-type strain. After 12 h, a significant majority
of the zebrafish infected with the mutant (SLS) failed to form
the expected pale lesions, as seen in wild-type infections (P 
0.02) (Fig. 1A). Also, at 12 h after infection, most of the
zebrafish in both infection groups remained viable (Fig. 1C),
and both the wild-type and the SLS mutant had multiplied to
similar extents in muscle tissue even though in the first 6 h
SLS bacteria grew at a slightly slower rate (Fig. 1B). How-
ever, it is important that the magnitude of this difference, while
statistically significant, is not striking (less than a 1-log differ-
ence, with overall burdens between 105 to 106 CFU), so the
proliferative ability of both strains was essentially the same.
Following this initial period, greater than 90% of zebrafish
infected with the wild type did not survive beyond day 2 (Fig.
1C). In contrast, greater than 60% of zebrafish infected with
the mutant were still viable at 40 h postinfection (Fig. 1C),
demonstrating that the loss of SLS rendered S. pyogenes sig-
nificantly less virulent (P  0.0043).
Infection by the SLS mutant promotes an elevated PMN
infiltrate. To determine the basis for the longer viability of
zebrafish infected by the mutant, histological analyses were
conducted on infected tissues recovered at 3-h intervals over a
48-h period. By 6 h the wild-type strain had produced the
characteristic extensive necrosis associated with large numbers
of extracellular streptococci, based on dissections along planes
of remnant tissue (Fig. 2A) (see also reference 54). SLS
mutant-infected tissue showed reduced necrosis, few visible
streptococci (Fig. 2B), and a vigorous infiltrate of PMNs (P 
0.001) (Fig. 2C). Thus, as reported for the murine model (3, 17,
31, 50, 64), the attenuation of the SLS mutant was associated
with a more robust inflammatory response.
S. pyogenes SLS mutant is attenuated for virulence in ze-
brafish embryos compared to the wild type. Zebrafish embryos
have been used to study the behavior of phagocytes during
inflammation (31, 50, 64) and to study early events in the
interaction between phagocytic cells and several facultative
FIG. 1. The SLS mutant is attenuated in the adult zebrafish model of necrotic myositis. Groups of zebrafish were challenged intramuscularly
with 105 CFU of mutant (SLS) or wild-type (WT) S. pyogenes. Significant differences are indicated by an asterisk. (A) Percentage of fish with
lesions at 6, 12, and 24 h. The data represent the average of 10 fish per experiment over three separate experiments at the indicated time points.
There were significantly fewer lesions (P  0.02) in the mutant group at each time point. (B) Numbers of CFU recovered from infected tissue at
6 and 12 h. Data represent the mean and standard deviation of three separate experiments. A significant difference was seen at 6 h but not at 12 h.
(C) Survival data presented as a Kaplan-Meier plot. Data are pooled from three independent experiments, each of which was conducted using 10
zebrafish per group. These data indicate that the mutant was significantly less lethal than the wild type (P  0.0043).
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intracellular pathogens, including Mycobacterium (18) and Sal-
monella (71). Based on these studies, we used microinjection to
introduce S. pyogenes into yolk sacs of embryos that were at
least 32 h postfertilization (Fig. 3A), reasoning that this would
require migration of inflammatory cells to the site as with
streptococcal deep-tissue infection. In our experiments, ap-
proximately 105 CFU of S. pyogenes delivered to the yolk sac
was lethal to	90% of embryos by 24 h, while at this time point
nearly all embryos remained viable with a similar dose of an
SLS strain (Fig. 3B), as did embryos injected with sterile PBS
(Fig. 3B). Overall, a comparison of wild-type and mutant vir-
ulence revealed that the mean time to death was significantly
shorter for wild-type infection than for infection with the mu-
tant (P  0.01). Infected embryos were sacrificed every 30 min
for up to 6 h postinfection, and the number of CFU was then
determined in homogenates. This analysis revealed that, sim-
ilar to results of the adult study, both the mutant and wild-type
strains multiplied to similar extents (Fig. 3C) over time, which
is consistent with analysis of in vitro growth curves at 30°C, the
temperature for zebrafish culture and infection (data not
shown); thus differences in strain survival are not the primary
explanation for the attenuated virulence, and this suggests that
a host factor may be involved.
SLS mutant bacteria induce increased PMN recruitment
in larvae. The observation that infection with the mutant was
associated with enhanced PMN recruitment in adult fish sug-
gested that PMN responses might also be an important host
factor limiting virulence in embryos. To test this, we injected
mutant and wild-type S. pyogenes into the well-developed dor-
sal muscle of transgenic pu.1 larvae (7 days postfertilization) in
which the myeloid lineage has previously been shown to ex-
presses GFP fluorescence that correlates with immunohisto-
chemistry staining for myeloid cells (36, 64, 74). The strepto-
cocci were intrinsically labeled with a fluorescent dye
(CellTracker Orange) and were readily visible in muscle when
infected larvae were examined by fluorescent microscopy (us-
ing CTO) (Fig. 4C and D). In larvae infected with wild-type
bacteria for 2 h, only a modest accumulation of GFP-positive
cells was observed at the site of infection (Fig. 4E). In
contrast, infection with SLS mutant bacteria led to a strik-
ing accumulation of GFP-positive cells (Fig. 4F). Further-
more, this accumulation overlapped with the location of the
mutant in the muscle (Fig. 4H). As with results in the adult
model, significantly higher numbers of PMNs were observed
to have infiltrated to the site of infection by the mutant (P 
0.0001) (Fig. 4I).
SLS alters epithelial cell signaling in a transepithelial
PMN migration assay. The zebrafish infection experiments
suggest that SLS is involved in reducing the number of PMNs
present at the site of streptococcal multiplication. This could
be due to the ability of SLS to kill PMNs (28, 35, 53) or to an
effect on local host cells that inhibits their ability to express
chemotactic alarm molecules. To distinguish between these
possibilities, we adapted an in vitro transepithelial PMN mi-
gration assay that has been used to assess how the interactions
between several pathogens and a polarized epithelium can lead
to the recruitment of PMNs (reviewed in reference 51). In
addition, the use of a polarized epithelium presents the epi-
thelial cells in a more physiological context and monitors PMN
migration in the more relevant basolateral-to-apical direction
(51). For the current analysis, human keratinocytes were em-
ployed because of their relevance to streptococcal infection
and because it has been shown that S. pyogenes binds to non-
polarized human keratinocytes and promotes a proinflamma-
tory response, characterized by enhanced expression of several
cytokines, and a more rapid release of prostaglandin E2 (65,
73). The HaCaT human keratinocyte cell line was used to
generate polarized monolayers on inverted permeable filter
supports, and then their apical surfaces were infected with S.
pyogenes. Subsequently, freshly isolated human PMNs were
exposed to the basolateral surface of the monolayer, and the
number of PMNs recruited to the apical surface was deter-
mined 1 h after infection. Upon the addition of 1 106 PMNs,
infection by the wild-type strain HSC5 resulted in recruitment
of approximately 25% of these PMNs (Fig. 5, left panel) and
approximately 46% for an unrelated wild-type strain, JRS4
FIG. 2. Infection by the SLS mutant demonstrates a neutrophil-rich infiltrate. Adult zebrafish were infected in the dorsal muscle by either the
wild type (WT) or the SLS mutant, as indicated. Zebrafish from each infection group were fixed in toto. Longitudinal sections (5 m thick) were
stained with hematoxylin and eosin, and then the area of injection/infection was examined by microscopy. The panels show samples from 6 h
postinfection with the wild-type strain HSC5 (A) and the SLS strain SagH (B). Features apparent in the micrographs are denoted as follows:
arrowheads, PMNs; asterisks, erythrocytes; m, striated muscle; and s, streptococci. The bar in the left panel represents 30 m, and the center panel
is shown at the same magnification. (C) Numbers of PMNs that infiltrated infected tissue as determined by microscopic examination of stained
sections by blinded observers. Data represent the mean and standard deviation of the number of individual PMNs observed per microscopic field
and are pooled from sections prepared from three infected zebrafish per experimental group. There were significantly more PMNs observed in
tissue infected by the SLS mutant (P  0.001).
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(Fig. 5, right panel). Furthermore, efficient recruitment re-
quired the presence of keratinocytes (Fig. 5, compare results
for the wild type with and without keratinocytes in the left
panel), suggesting that host-pathogen interactions at the apical
keratinocyte surface were generating chemotactic signals re-
leased to the basolateral membrane. Supporting this was the
observation that an M protein-deficient mutant, which cannot
adhere to keratinocytes (59), and a mutant that cannot express
the proinflammatory molecule SLO (65) had reduced abilities
to recruit PMNs and recruited these cells only at the levels
observed in the absence of keratinocytes (Fig. 5). In contrast,
infection with the SLS mutant produced a significantly
greater inflammatory response than the wild-type strain (P 
0.001) (Fig. 5, right panel), and this response was more than
fourfold greater than that produced by the M protein-deficient
mutant (Fig. 5, left panel). Furthermore, this enhanced level of
recruitment was dependent on the presence of keratinocytes
(Fig. 5, compare results for the SLS strain with and without
keratinocytes). The altered pattern of migration observed over
the course of the assay was likely not due to any direct effect of
SLS on PMNs as greater than 95% of the PMNs recruited by
either the wild-type strain or the SLS mutant were viable
(data not shown). When results were normalized for the total
number of PMNs recruited, there was no significant difference
in the production of ROS by PMNs during transepithelial
migration (Fig. 6A), nor was there a significant difference in
the ability of either streptococcal strain to promote neutrophil
apoptosis (Fig. 6B) within the observed time frame.
Neutrophil extravasation is altered by SLS in a mouse
model of streptococcal infection. In order to determine what
step in neutrophil recruitment might be involved in the delayed
presence of neutrophils at the recruitment site, we compared
the recruitment kinetics of neutrophils after subcutaneous in-
fection with wild-type and SLS bacteria in mice using in vivo
two-photon microscopy. Neutrophils were identified by their
characteristic shape, movements, and fluorescence, which is
brighter than that of macrophages/monocytes, as previously
described (22, 78). Within minutes of infection with either the
wild-type or SLS strain, similar numbers of GFP-positive
neutrophils were found rolling along the lumen of small vessels
near the site of injection and adhering firmly to the surface of
the endothelium (Fig. 7A; see also Movies WT and SLS in
the supplemental material). In response to inoculation with
wild-type bacteria, most neutrophils remained in the vessels for
tens of minutes before appreciable numbers extravasated
(
time at which 50% of the imaged cells are still in the vessel,
52 min) (Fig. 7B; see also Movie WT in the supplemental
material) and began to migrate through the connective tissues.
In contrast, the rate of extravasation of neutrophils recruited in
response to SLS bacteria was significantly increased (time at
which 50% of the imaged cells are still in the vessel, 28 min)
(Fig. 7B; see also Movie SLS in the supplemental material).
Thirty-five minutes after infection with the wild type, greater
than 80% of neutrophils remained in the blood vessels,
whereas at the same time during SLS infection, less than 40%
of the neutrophils were inside vessels. However, once neutro-
phils completed diapedesis, they migrated with similar veloci-
ties (Fig. 7C) and directional biases (Fig. 7D) in response to
either wild-type or SLS infection. This response is highly
localized to the infection site since we saw similar results in the
same mouse paw that had wild-type bacteria injected in one
toe and SLS bacteria injected into an adjacent toe. In sum-
mary, in this model, neutrophils in both types of infections
appeared to be recruited similarly to the site of infection, and,
once they had exited the vessel into the tissue, they also ap-
peared to behave similarly. The rate-limiting step appears to be
the difference in timing of the exodus of the neutrophils from
the vessel lumen into the tissue and not their overall accumu-
lation, which could explain the earlier appearance of PMNs in
SLS infections than in wild-type infections.
IL-8 expression was not altered between keratinocytes in-
fected by wild-type or SLS streptococci. Both mouse and
transwell data suggest that SLS has a local effect on PMN
migration that may involve alterations in chemotactic signaling
FIG. 3. S. pyogenes is virulent in zebrafish embryos but, as in adult
zebrafish, the SLS mutant is not as virulent. (A) Yolk sac injections.
The site of injection of 1 105 CFU of wild-type (WT) S. pyogenes, the
SLS mutant, or PBS alone (Ctrl) in the yolk sac is indicated by the
arrow. The diagram was adapted from Kimmel et al. (39) with per-
mission of the publisher, John Wiley & Sons, Inc. (B) Analysis of
virulence. The survival data of injected embryos are presented as a
Kaplan-Meier plot. Infected embryos were examined for viability every
2 h by microscopy. Data shown are pooled from three independent
experiments using 15 embryos per group. These data show that the
SLS mutant is significantly attenuated (P  0.011). (C) Infected
embryos were sacrificed every 30 min during the first 6 h of infection
for assessment of the number of CFU. Groups of five embryos each
were examined at each time point for each strain analyzed. The data
shown represent the mean and standard deviation of three indepen-
dent experiments. There was no significant difference between groups.
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FIG. 4. The SLS mutant also promotes a PMN-rich infiltrate in embryos. pu.1 larvae (7 days postfertilization) which express GFP fluorescence
specifically in cells of the myeloid lineage were injected in the dorsal muscle with 103 CFU of either the wild type (WT) or the SLS mutant
intrinsically labeled with the fluorescent dye CTO at the site indicated by the red boxes in panels A and B. Infected larvae were examined by
fluorescent microscopy at 2 h postinfection for CTO fluorescence (C and D and GFP fluorescence (E and F; PMNs are indicated by white arrows).
As noted by Hsu et al., in the larval form, the skeletal muscle (even in wild-type-infected fish) contributes background fluorescence that is easily
distinguished from individual myeloid cells (36). The columns show images taken from single representative larvae, oriented as indicated in the
top panels (A and B), that were infected with the wild type (WT) or the SLS mutant. Panels G and H show the merged images. The site of
injection in each fish is demarcated in the micrographs by the boxes with the broken white line. Magnification,10. The insets outlined by the boxes
with the unbroken white lines show the injection site at a higher magnification (40). The diagram in panels A and B was adapted from Kimmel
et al. (39) with permission of the publisher, John Wiley & Sons, Inc. (I) The number of PMNs that infiltrated the infected tissue as determined
by microscopic examination by blinded observers. Data shown represent the mean and standard deviation of the number of individual PMNs
observed per microscopic field and pooled from three infected zebrafish per experimental group. As with the results of infections of adults, there
were significantly more PMNs observed in tissue infected by the SLS mutant than in wild-type-infected tissue (P  0.0001).
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by adjacent host cells. The major chemotactic cytokine for
PMNs known to be involved in streptococcal infection of
keratinocytes is IL-8 (73), so IL-8 activity was evaluated in the
apical and basolateral chambers of the transwells to see if the
altered pattern of migration observed in SLS strains might be
related to differences in IL-8 concentration. Tissue culture
supernatants were collected from both chambers after 1 h of
infection and analyzed for the presence of IL-8. IL-8 concen-
trations were similar between wild-type and mutant transwell
infections. The apical chambers of both strains had signifi-
cantly less IL-8 than the basolateral chambers of both strains
(Fig. 8). These results demonstrate no difference in IL-8 ex-
pression levels between the two types of infection and further
suggest that PMNs would be migrating against the IL-8 gradi-
ent to interact with the bacteria at the apical side of the cell
since IL-8 is higher in the basolateral wells than in the apical
wells in both types of infection. Furthermore, these results
would imply that IL-8 is not a major contributor to neutrophil
recruitment across the transwell epithelial layer and that an-
other chemotactic agent might be involved in this effect.
DISCUSSION
Analyzing the early events in infection can present a consid-
erable challenge due to the limitations inherent in many ani-
mal models, including the relatively low numbers of bacteria
present at early time points and the difficulties associated with
imaging the host response in real time in unfixed tissues. The
fact that there are relatively few representative animal models
for the myriad forms of streptococcal disease provides an ad-
ditional complication for the study of the early elements of
host-pathogen interaction for S. pyogenes. Our adaptation of
multiple models that are particularly well suited to interrogate
the first few hours of infection revealed that SLS makes an
important contribution to the ability of S. pyogenes to manip-
ulate the host inflammatory response during the early stages of
infection.
Zebrafish embryos and larvae have numerous advantages for
the study of inflammatory processes; in particular, their small
size and transparency have been used to great advantage for
imaging phagocyte behavior in real time using various light
microscopy techniques (31) and using fluorescent microscopy
in combination with transgenic lines engineered to express
fluorescent proteins in cells of the myeloid lineage (36, 50, 64).
Zebrafish have well-developed innate and adaptive immune
systems, with the former including both Toll-like receptors that
are highly conserved in mammals (37, 52) and conserved sig-
naling pathways that include adaptor proteins such as MyD88
(72). It has been shown that inflammation is both induced and
resolved over a time course similar to time courses of the more
FIG. 5. Neutrophil recruitment is altered by SLS and requires the
presence of keratinocytes. The number of PMNs recruited to the
basolateral surface of a polarized HaCaT keratinocyte monolayer (ke-
ratinoctyes) following infection with various S. pyogenes strains. Mono-
layers were infected at their apical surfaces at 10 CFU/epithelial cell,
and then 1  106 PMNs were added at the basolateral surface of the
monolayer. The number of PMNs recruited to the apical surface was
enumerated at 60 min postinfection and is shown relative to the num-
ber recruited in response to each wild-type strain. PMN recruitment in
the absence of a monolayer is also shown (no keratinoctyes). In the left
panel, strains derived from HSC5 (WT) include the SLS mutant
SagH and the M protein-deficient mutant Emm (M). In the right
panel, the SLO-deficient mutant SLO1 (SLO) was derived from JRS4
(WT). An asterisk indicates that recruitment by the indicated strain
was significantly different from the wild type (P  0.001) under the
same conditions. Data shown represent the mean and standard devi-
ation of the mean derived from three independent experiments.
FIG. 6. Characterization of PMN exposed to S. pyogenes in vitro
under conditions of transwell infections. (A) The ability of PMNs to
produce a respiratory burst in the presence of keratinocytes infected
with wild-type (WT) or SLS S. pyogenes is shown. Human PMNs
loaded with an indicator dye that fluoresces in the presence of intra-
cellular ROS were tested in the transepithelial migration assays, and
the data are presented as the amount of fluorescence (relative fluo-
rescent units [RFU]) per 104 migrated cells. Data represent the mean
and standard deviation of six samples from two independent experi-
ments. (B) The number of PMNs undergoing apoptosis when exposed
to wild-type (WT) or SLS S. pyogenes is shown, as determined by
staining with annexin V-PE. Data presented show the ratio of the
number of apoptotic cells observed upon exposure to the indicated
strain versus the number observed in the absence of any streptococci
and represent the mean and standard deviation of two independent
experiments, with samples analyzed in duplicate. Differences between
mean values at each time point shown in both panels were not signif-
icant.
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well-developed mammalian experimental systems (50, 64), and
studies of PMN migration in zebrafish using real-time meth-
odologies have revealed novel PMN behaviors such as retro-
grade chemotaxis (50). The present study extends the utility of
using zebrafish for analysis of the early stages of infection by an
extracellular bacterial pathogen, and further studies using
these models should be useful for understanding how S. pyo-
genes balances the expression of its pro- and anti-inflammatory
virulence factors in response to both tissue-specific and disease
progression cues.
Similarly, two-photon microscopy has also been applied with
great success to studying the immune system in vivo and, more
recently, neutrophil recruitment during inflammation in real
time (11, 62, 78). Our use of two-photon imaging supports a
FIG. 7. In vivo imaging of neutrophil recruitment in mice infected with wild-type (WT) and SLS streptococci. Intravital imaging was
performed at the injection site on the paws of LysM-eGFP mice after subcutaneous infection with streptococci. Data were pooled from three
independent experiments. (A) Representative time-lapse images of neutrophil recruitment in response to wild-type and SLS mutant bacteria.
Images are three-dimensionally rendered volumes (200 m by 225 m by 75 m). Neutrophils (eGFP) appear green, collagen fibers in the
connective tissue appear blue, and blood vessels (unless occluded by cells) appear red. White lines show the outline of blood vessels based on both
the fluorescent-dextran signal and the characteristic flow of circulating neutrophils. White arrowheads show extravasated neutrophils at 24 min.
The time stamp indicates minutes postinfection. The scale grid is labeled in micrometers. (B) The percentage  standard deviation of neutrophils
remaining in blood vessels over time in LysM-GFP mice infected with wild-type and SLS bacteria. The curves are statistically different (P  0.01)
with both Pearson (parametric) and Spearman (nonparametric) correlations. (C) Interstitial neutrophil migration velocity. The plot shows the
median track velocities of 25 extravasated neutrophils in wild-type and SLS mutant infections. No statistical differences were observed. (D) The
meandering index was calculated for each track in panel C. The median meandering indices of neutrophils after wild-type and SLS mutant
infection were not statistically different.
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role for SLS in acting to impede diapedesis to prevent PMN
migration into infected tissue. These data suggest that the
reduced virulence of SLS mutants results from a failure to
inhibit neutrophil recruitment rather than via a loss of any of
its reported proinflammatory activities.
While it has been well recognized that S. pyogenes can ex-
press numerous proinflammatory virulence factors like SLO
(65) and M protein (60), it has also been noted that S. pyogenes
can express factors capable of active suppression of inflamma-
tion. These include the cell wall-associated proteases SpcA and
SpcC. The former is a subtilysin family protease that cleaves
and inactivates the chemotactic C5a component of comple-
ment (12) while the latter is a serine protease that degrades
CXC-type chemokines, such as IL-8, keratinocyte-derived che-
mokine, and MIP-2 (19, 32, 33). Mutants that cannot express
these proteases have been reported to possess altered viru-
lence in several animal models of infection (33, 38). Interest-
ingly, as proteases, the anti-inflammatory activities of both
SpcA and SpcC require them to come into direct contact with
their substrates. Furthermore, both are covalently anchored to
the peptidoglycan of the streptococcal cell surface by the sor-
tase pathway (8, 33), suggesting that they exert their influence
only on substrates present in the bacterium’s local environment
that have been produced following the onset of inflammation.
This contrasts with the inhibitory activity of SLS, which acts at
the apical surface of a cell or epithelium and exerts its influ-
ence at a distance from its target cells, PMNs, which are pri-
marily located on the basolateral surface of the cell. This is
most likely accomplished by interfering with local chemotactic
signaling that most likely does not involve IL-8. Thus, all these
anti-inflammatory signals may work in concert, with SLS acting
to inhibit chemotactic signals produced during the initial strep-
tococcus-host cell interaction and the surface proteases acting
subsequently to eliminate signaling molecules that are pro-
duced by the host’s response to an increasing tissue burden of
the replicating pathogen as the infection progresses.
The idea that SLS promotes the ability of S. pyogenes to
establish a niche in host tissue is consistent with the proposal
that SLS was originally a bacteriocin that was subsequently
adapted for modulation of host cell behavior (75). This hy-
pothesis is based on the similarity between the structure of the
SLS operon and the structures of operons encoding bacterio-
cins, which are often produced by bacteria to control and
out-compete resident flora (20). This capability provides an
advantage to a bacterium attempting to establish a niche fol-
lowing its introduction into a naïve host. The SLS operon also
encodes a putative immunity protein similar to the proteins
encoded by bacteriocin operons (56). These proteins act to
protect the producing bacterium from damage caused by its
own bacteriocin, which, like SLS, functions by damaging the
cell membrane (20). However, unlike SLS, bacteriocins are
typically incapable of damaging the membranes of eukaryotic
cells (20). There are notable exceptions, including the bacte-
riocin/cytolysin of Enterococcus faecalis, which can damage
both bacterial and host cell membranes and does contribute to
virulence (13). The process by which SLS may have been
adapted from a bacteriocin is not known. However, the obser-
vation that several other membrane-active toxins with some
similarity to bacteriocins and/or SLS have been found in other
pathogens (25, 63) suggests that the adaptation of bacteriocins
for host-pathogen interactions may be a common theme.
Another similarity to many bacteriocins is that expression of
SLS is subject to a high degree of regulation that is manifested
at the level of transcription (27). This is consistent with the
idea that S. pyogenes may balance the expression of its pro- and
anti-inflammatory factors during distinct stages of the infection
in order to manipulate the overall magnitude of the host’s
inflammatory response. Additional support for this has come
from the observations that disregulation of virulence factor
expression via mutation of several global regulators can signif-
icantly enhance streptococcal tissue damage and invasiveness
in murine models (16, 21, 34, 45, 68). In a similar vein, the
presence of multiple pro- and anti-inflammatory factors may
suggest that the same overall balance can be obtained using
different combinations of these factors in different strains. The
observation that the contribution of SLS to pathogenesis in
murine models is often strain specific and influenced by the
level of expression of other virulence traits (24, 67) may reflect
this notion of overall balance. This model would predict that
growth of S. pyogenes in tissues that the organism has not
evolved to infect may not provide the expected cues for the
regulatory program, which could lead to an unbalanced ma-
nipulation of the host’s response. In turn, this could produce
consequences like the sustained dampening of the inflamma-
tory response that has been noted to be associated with poor
outcomes for infection of the fascia and muscle (1, 32); this
model is also consistent with studies that have established that
the rate of bacterial killing is determined by the concentration
of neutrophils and not the ratio of neutrophils to bacteria (46).
A delay in the recruitment of neutrophils to extravascular sites
could allow a small number of bacteria to proliferate to high
numbers, causing significant local tissue damage. This is also
consistent with our bacterial recovery data, in which growth
rates are initially slower in the mutant but subsequently equal-
ize at later time points, suggesting that early on the presence of
neutrophils is important to streptococcal clearance but that at
later time points other streptococcal virulence factors are in-
volved (e.g., C5a peptidase and DNases that help in evasion
FIG. 8. IL-8 expression is similar in transwells infected with either
wild-type or SLS-deficient streptococci. Polarized HaCaT keratinocyte
monolayers were treated with 1  106 bacteria/monolayer of wild-type
(WT) bacteria, an equivalent concentration of SLS bacteria, or an
equivalent volume of chemotaxis medium alone as a control (Ctrl).
The monolayers were assessed for IL-8 secretion in the apical and
basolateral compartments. Each strain was represented by 10 wells per
experiment, and data presented are representative of an experiment
performed three times.
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from neutrophils) and make neutrophil presence and bacterial
number less pertinent to the progression of the infection. Even
at the 6-h time point, the difference in bacterial numbers is not
striking, and, again, there is no difference at 12 h, so the growth
rate of strains during infection is not likely the main reason for
the differences in neutrophil behaviors. Thus, the ability of S.
pyogenes to balance expression of its pro- and anti-inflamma-
tory factors likely plays a critical role in its ability to cause
acute infection.
The strategy of using both pro- and anti-inflammatory fac-
tors to manipulate the host’s response has been reported for
other extracellular pathogens. For example, Staphylococcus au-
reus (48) uses global regulators of transcription, like the Agr
quorum-sensing pathway, to balance the expression of factors
involved colonization and biofilm formation with the expres-
sion of several proinflammatory toxins at different stages of
infection, favoring expression of colonization factors at lower
cell densities and toxins at higher cell densities (reviewed in
reference 9). Similarly, the gram-negative bacterium Yersinia
pestis progresses from an initial anti-inflammatory state to a
highly proinflammatory state within a few days of infection of
the lung (42), and this process is dependent on temporal reg-
ulation of the plasminogen activator Pla (43). When combined
with the data presented here for S. pyogenes, these observa-
tions suggest that the ability to balance expression of pro- and
anti-inflammatory factors in temporally specific patterns may
be emerging as a theme for the extracellular pathogens that
cause acute infections.
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